Aspire Medical in US trial for OSA (obstructive sleep apnoea) tongue implant
This article was originally published in Clinica
Executive Summary
Aspire Medical is hoping to take to the US obstructive sleep apnoea (OSA) market in late 2008/early 2009 a tongue and jaw-based implant that it claims will provide a less invasive surgical option for patients.